| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.5M | -32.0% | +196.7% |
| R&D Expense | $77K | +91.9% | +79.3% |
| SG&A Expense | $2.5M | -5.4% | +42.8% |
| Operating Income | -$860K | -251.6% | +14.4% |
| Interest Expense | $934K | -7.4% | -2.4% |
| Pre-tax Income | -$1.9M | -257.1% | +3.8% |
| Net Income | -$1.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $629K | +95.3% | +1748.7% |
| Accounts Receivable | $3.2M | -35.8% | +58.0% |
| Inventory | $8K | — | — |
| Current Assets | $4.2M | -26.0% | +43.2% |
| Total Assets | $52.1M | +4.1% | +22.1% |
| Current Liabilities | $28.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | — |
| Investing Cash Flow | -$637K | — | — |
| Financing Cash Flow | $5.0M | — | — |
| -259.4% |
| +3.6% |
| -12.9% |
| -16.6% |
| Total Liabilities | $32.0M | -12.1% | -46.9% |
| Stockholders' Equity | $20.2M | +47.0% | +215.4% |